Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark C Genovese, MD, Professor of Medicine
Division of Immunology and Rheumatology - Stanford University - USA
Principal InvestigatorKOL profile → - TWJ Huizinga, Prof Dr
Dpt of Rheumatology - Leiden University Medical Center - The Netherlands
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
262 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigational Site Number 032005
Buenos Aires, Argentina
- Investigational Site Number 032007
Buenos Aires, Argentina
- Investigational Site Number 032008
Buenos Aires, Argentina
- Investigational Site Number 032006
Caba, Argentina
- Investigational Site Number 032002
Córdoba, Argentina
- Investigational Site Number 032003
Córdoba, Argentina
- Investigational Site Number 032012
Mar del Plata, Argentina
- Investigational Site Number 032011
Quilmes, Argentina
- Investigational Site Number 032010
Ramos Mejía, Argentina
- Investigational Site Number 032001
Rosario, Argentina
- Investigational Site Number 032004
San Miguel de Tucumán, Argentina
- Investigational Site Number 032009
Zárate, Argentina
- Investigational Site Number 036003
Camperdown, Australia
- Investigational Site Number 036005
Clayton, Australia
- Investigational Site Number 036012
Fitzroy, Australia
- Investigational Site Number 036010
Garran, Australia
- Investigational Site Number 036004
Heidelberg West, Australia
- Investigational Site Number 036009
Herston, Australia
- Investigational Site Number 036002
Malvern East, Australia
- Investigational Site Number 036001
Maroochydore, Australia
- Investigational Site Number 036006
St Leonards, Australia
- Investigational Site Number 036011
Sydney, Australia
- Investigational Site Number 036014
Victoria Park, Australia
- Investigational Site Number 036007
Woodville, Australia
- Investigational Site Number 040001
Graz, Austria
- Investigational Site Number 040002
Vienna, Austria
- Investigational Site Number 112001
Minsk, Belarus
- Investigational Site Number 112002
Minsk, Belarus
- Investigational Site Number 056003
Genk, Belgium
- Investigational Site Number 056001
Liège, Belgium
- Investigational Site Number 076008
Campinas, Brazil
- Investigational Site Number 076012
Campinas, Brazil
- Investigational Site Number 076001
Curitiba, Brazil
- Investigational Site Number 076006
Goiânia, Brazil
- Investigational Site Number 076010
Juiz de Fora, Brazil
- Investigational Site Number 076004
Porto Alegre, Brazil
- Investigational Site Number 076005
Rio de Janeiro, Brazil
- Investigational Site Number 076011
Salvador, Brazil
- Investigational Site Number 076002
São Paulo, Brazil
- Investigational Site Number 076003
São Paulo, Brazil
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2010
- Primary completion
- 31 Oct 2013
- Completion
- 31 Oct 2013
- Last update posted
- 28 Jun 2017
- Registered enrollment
- 1,675
- Registry id
- NCT01061736
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.